NCT00293761已完成3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 109
- 主要终点
- Mean IOP
研究概览
简要总结
The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients of either sex of any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.
- •Other protocol-defined inclusion criteria may apply.
排除标准
- •Under age
- •Other protocol-defined exclusion criteria may apply.
研究组 & 干预措施
Travatan, Investigational
Experimental
干预措施: Travoprost, Investigational (Drug)
Travatan
Active Comparator
干预措施: Travoprost (TRAVATAN) (Drug)
结局指标
主要结局
Mean IOP
次要结局
未报告次要终点
研究者
相似试验
已完成
2 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-angle GlaucomaNCT00287521Alcon Research87
已完成
3 期
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00314158Alcon Research523
已完成
3 期
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00314171Alcon Research437
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00293787Alcon Research156
已完成
3 期
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular HypertensionNCT00293800Alcon Research173
